Roger Crystal, Chief Executive Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 32,600 shares at $19.23 ($586K) on 2018-10-03, disclosed to the SEC on 2018-10-04.
Open-market sale of $586k OPNT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.51 | 10,144 | $178K | 30.3% |
| 2 | $17.51 | 10,144 | $178K | 30.3% |
| 3 | $19.23 | 4,300 | $83K | 14.1% |
| 4 | $18.43 | 4,006 | $74K | 12.6% |
| 5 | $18.43 | 4,006 | $74K | 12.6% |
| Total | $17.96 avg | 32,600 |
| $586K |
| 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $203K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $25K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $104K | — | Filing → |